miR-487b lentiviral silencing

miR-487b lentiviral silencing is an experimental gene therapy approach designed to inhibit the invasive potential of glioblastoma multiforme (GBM) cells. Developed by researchers at Baylor College of Medicine and collaborating institutions, this modality utilizes a lentiviral vector to deliver silencing sequences (typically short hairpin RNA) targeting microRNA-487b (miR-487b). miR-487b has been identified as a key driver of GBM invasion, found to be significantly upregulated in invasive tumor cells compared to those in the tumor core. In preclinical patient-derived orthotopic xenograft (PDOX) models, silencing miR-487b has demonstrated the ability to suppress cell migration and significantly inhibit invasive growth into normal brain tissue without affecting overall tumor proliferation. This therapeutic effect is achieved through the derepression of downstream target genes such as RDX, PDK1, and PRKAA2, which are normally suppressed by miR-487b to promote an invasive phenotype.

Other names

lentivirus-mediated silencing of miR-487bmiR-487b knockdownmiR487b knockdownmiR 487b knockdownlentiviral miR-487b inhibition